Tumor Necrosis Factor-α and Its Inducer Inhibit Morphine-Induced Rewarding Effects and Sensitization

Biological Psychiatry

Volumn 62, Issue 6, 2007, Pages 658-668

  Niwa, Minae ^a   Nitta, Atsumi ^a   Yamada, Yuichiro ^a   Nakajima, Akira ^a   Saito, Kuniaki ^b   Seishima, Mitsuru ^b   Noda, Yukihiro ^a,c   Nabeshima, Toshitaka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Faculty of Pharmacy   (Japan)

Author keywords

Dopamine (DA); Leu Ile; morphine (MOR); rewarding effect; sensitization; tumor necrosis factor (TNF )

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR; ISOLEUCINE; LEUCYLISOLEUCINE; MESSENGER RNA; MORPHINE; NALOXONE; OPIATE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; DRUG MECHANISM; EXTRACELLULAR SPACE; HOT PLATE TEST; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LOCOMOTION; MALE; MICRODIALYSIS; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REWARD; SENSITIZATION; WITHDRAWAL SYNDROME;

ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; DIPEPTIDES; HABITUATION, PSYCHOPHYSIOLOGIC; MALE; MICE; MICE, INBRED C57BL; MORPHINE; MORPHINE DEPENDENCE; MOTOR ACTIVITY; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; REWARD; RNA, MESSENGER; SPATIAL BEHAVIOR; SUBSTANCE WITHDRAWAL SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34250898929     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.10.009     Document Type: Article

References (58)

1. Albensi B.C., and Mattson M.P. Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity. Synapse 35 (2000) 151-159
2. Aloe L., and Fiore M. TNF-α expressed in the brain of transgenic mice lowers central tyrosine hydroxylase immunoreactivity and alters grooming behavior. Neurosci Lett 238 (1997) 65-68
3. Beattie E.C., Stellwagen D., Morishita W., Bresnahan J.C., Ha B.K., Von Zastrow M., et al. Control of synaptic strength by glial TNF alpha. Science 295 (2002) 2282-2285
4. Bluthe R.M., Pawlowski M., Suarez S., Parnet P., Pittman Q., Kelley K.W., et al. Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice. Psychoneuroendocrinology 19 (1994) 197-207
5. Bonci A., and Williams J.T. Increased probability of GABA release during withdrawal from morphine. J Neurosci 17 (1997) 796-803
6. Boudreau A.C., and Wolf M.E. Behavioral sensitization to cocaine is associated with increased AMPA receptor surface expression in the nucleus accumbens. J Neurosci 25 (2005) 9144-9151
7. Brase D.A., Loh H.H., and Way E.L. Comparison of the effects of morphine on locomotor activity, analgesia and primary and protracted physical dependence in six mouse strains. J Pharmacol Exp Ther 201 (1977) 368-374
8. Cen X., Nitta A., Ohya S., Zhao Y., Ozawa N., Mouri A., et al. An analogue of dipeptide-like structure of FK506 increases GDNF expression through CREB activated by Hsp90/Akt signaling pathway. J Neurosci 26 (2006) 3335-3344
9. Chavkin C., and Goldstein A. Opioid receptor reserve in normal and morphine-tolerant guinea pig ileum myenteric plexus. Proc Natl Acad Sci U S A 81 (1984) 7253-7257
10. Di Chiara G., and North R.A. Neurobiology of opioid abuse. Trends Pharmacol Sci 13 (1992) 185-193
11. Everitt B.J., and Wolf M.E. Psychomotor stimulant addiction: A neural systems perspective. J Neurosci 22 (2002) 3312-3320
12. Franklin K.B.J., and Paxinos G. The Mouse Brain in Stereotaxic Coordinates (1997), Academic press, San Diego
13. Funada M., Suzuki T., Narita M., Misawa M., and Nagase H. Blockade of morphine reward through the activation of κ-opioid receptors in mice. Neuropharmacology 32 (1993) 1315-1323
14. Giros B., Jaber M., Jones S.R., Wightman R.M., and Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379 (1996) 606-612
15. Guha M., Bai W., Nadler J.L., and Natarajan R. Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J Biol Chem 275 (2000) 17728-17739
16. 2+/calmodulin-dependent signal cascade. Behav Brain Res 152 (2004) 263-270
17. 3H-dopamine in rat brain tissue slices. Biochem Pharmacol 24 (1975) 847-852
18. Itoh A., Shiotani T., Nakayama S., Mamiya T., Hasegawa T., Noda Y., et al. Attenuation of the development of morphine dependence/tolerance by nefiracetam: Involvement of adenosine 3':5'-cyclic monophosphate system. Behav Brain Res 115 (2000) 65-74
19. Johnson S.M., and Fleming W.W. Mechanisms of cellular adaptive sensitivity changes: Applications to opioid tolerance and dependence. Pharmacol Rev 41 (1989) 435-488
20. Johnson S.W., and North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12 (1992) 483-488
21. Kalivas P.W., and Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 16 (1991) 223-244
22. Koob G.F. Drugs of abuse: Anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13 (1992) 177-184
23. Koob G.F., and Nestler E.J. The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci 9 (1997) 482-497
24. Koob G.F., Sanna P.P., and Bloom F.E. Neuroscience of addiction. Neuron 21 (1998) 467-476
25. Kuwahara M., Sugimoto M., Tsuji S., Miyata S., and Yoshida A. Cytosolic calcium changes in a process of platelet adhesion and cohesion on a von Willebrand factor-coated surface under flow conditions. Blood 94 (1999) 1149-1155
26. Laakso A., Mohn A.R., Gainetdinov R.R., and Caron M.G. Experimental genetic approaches to addiction. Neuron 36 (2002) 213-228
27. Law P.Y., Hom D.S., and Loh H.H. Loss of opiate receptor activity in neuroblastoma X glioma NG108-15 hybrid cells after chronic opiate treatment. A multiple-step process. Mol Pharmacol 22 (1982) 1-4
28. Maier S.F., and Watkins L.R. Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 105 (1998) 83-107
29. Mamiya T., Noda Y., Ren X., Hamdy M., Furukawa S., Kameyama T., et al. Involvement of cyclic AMP systems in morphine physical dependence in mice: Prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor. Br J Pharmacol 132 (2001) 1111-1117
30. Matthews R.T., and German D.C. Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine. Neuroscience 11 (1984) 617-625
31. Messer C.J., Eisch A.J., Carlezon Jr. W.A., Whisler K., Shen L., Wolf D.H., et al. Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron 26 (2000) 247-257
32. Miyamoto Y., Yamada K., Nagai T., Mori H., Mishina M., Furukawa H., et al. Behavioral adaptations to addictive drugs in mice lacking the NMDA receptor ε{lunate}1 subunit. Eur J Neurosci 19 (2004) 151-158
33. Mizoguchi H., Yamada K., Mizuno M., Mizuno T., Nitta A., Noda Y., et al. Regulations of methamphetamine reward by extracellular signal-regulated kinase 1/2/ets-like gene-1 signaling pathway via the activation of dopamine receptors. Mol Pharmacol 65 (2004) 1293-1301
34. Nagai T., Kamei H., Ito M., Hashimoto K., Takuma K., Nabeshima T., et al. Modification by the tissue plasminogen activator-plasmin system of morphine-induced dopamine release and hyperlocomotion, but not anti-nociceptive effect in mice. J Neurochem 93 (2005) 1272-1279
35. Nagai T., Noda Y., Ishikawa K., Miyamoto Y., Yoshimura M., Ito M., et al. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization. J Neurochem 92 (2005) 660-667
36. Nagai T., Yamada K., Yoshimura M., Ishikawa K., Miyamoto Y., Hashimoto K., et al. The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release. Proc Natl Acad Sci U S A 101 (2004) 3650-3655
37. Nakajima A., Yamada K., Nagai T., Uchiyama T., Miyamoto Y., Mamiya T., et al. Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity. J Neurosci 24 (2004) 2212-2225
38. Narita M., Funada M., and Suzuki T. Regulations of opioid dependence by opioid receptor types. Pharmacol Ther 89 (2001) 1-15
39. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2 (2001) 119-128
40. Nestler E.J. From neurobiology to treatment: Progress against addiction. Nat Neurosci 5 (2002) 1076-1079
41. Nitta A., Nishioka H., Fukumitsu H., Furukawa Y., Sugiura H., Shen L., et al. Hydrophobic dipeptide Leu-Ile protects against neuronal death by inducing brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis. J Neurosci Res 78 (2004) 250-258
42. Niwa M, Nitta A, Yamada Y, Nakajima A, Saito K, Seishima M, et al (in press): An inducer for glial cell line-derived neurotrophic factor and tumor necrosis factor-α protects methamphetamine-induced reward and sensitization. Biol Psychiatry.
43. Noda Y., Miyamoto Y., Mamiya T., Kamei H., Furukawa H., and Nabeshima T. Involvement of dopaminergic system in phencyclidine-induced place preference in mice pretreated with phencyclidine repeatedly. J Pharmacol Exp Ther 286 (1998) 44-51
44. Oliverio A., Castellano C., and Eleftheriou B.E. Morphine sensitivity and tolerance: A genetic investigation in the mouse. Psychopharmacologia 42 (1975) 219-224
45. Puttfarcken P.S., Werling L.L., and Cox B.M. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: A useful model for the study of tolerance at μ opioid receptors. Mol Pharmacol 33 (1988) 520-527
46. Rahman I., and MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: Therapeutic approaches. Free Radic Biol Med 28 (2000) 1405-1420
47. Ren X., Noda Y., Mamiya T., Nagai T., and Nabeshima T. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase. Behav Brain Res 152 (2004) 243-250
48. Robinson T.E., and Berridge K.C. The psychology and neurobiology of addiction: An incentive-sensitization view. Addiction 95 suppl 2 (2000) S91-S117
49. Seiden L.S., Sabol K.E., and Ricaurte G.A. Amphetamine: Effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 33 (1993) 639-677
50. Taniguchi T., Tanaka M., Ikeda A., Momotani E., and Sekikawa K. Failure of germinal center formation and impairment of response to endotoxin in tumor necrosis factor α deficient mice. Lab Invest 77 (1997) 647-658
51. Terwilliger R.Z., Beitner-Johnson D., Sevarino K.A., Crain S.M., and Nestler E.J. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res 548 (1991) 100-110
52. Tsuji S., Sugimoto M., Miyata S., Kuwahara M., Kinoshita S., and Yoshioka A. Real-time analysis of mural thrombus formation in various platelet aggregation disorders: Distinct shear-dependent roles of platelet receptors and adhesive proteins under flow. Blood 94 (1999) 968-975
53. Vassali P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10 (1992) 411-452
54. Vezina P., and Stewart J. Conditioning and place-specific sensitization of increases in activity induced by morphine in VTA. Phamacol Biochem Behav 20 (1984) 925-934
55. Wada R., Tifft C.J., and Proia R.L. Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. Proc Natl Acad Sci U S A 97 (2000) 10954-10959
56. Wise R.A. Neurobiology of addiction. Curr Opin Neurobiol 6 (1996) 243-251
57. Yamada K., Iida R., Miyamoto Y., Saito K., Sekikawa K., Sedishima M., et al. Neurobehavioral alternations in mice with a targeted deletion of the tumor necrosis factor-alpha gene: Implication for emotional behavior. J Neuroimmunol 111 (2000) 131-138
58. Yamada K., Nagai T., and Nabeshima T. Drug dependence, synaptic plasticity, and tissue plasminogen activator. J Pharmacol Sci 97 (2005) 157-161